Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSThis is the seventh Launch Excellence white paper that IQVIA has published since 2007, but never has the Launch Excellence environment changed so dramatically and comprehensively as in the last year. To respond, we’ve divided our launch cohort into a pre-Pandemic cohort, which we have followed for 18 months of performance unaffected by the Pandemic, and the launches from late 2019, which have launched into the Pandemic during part or all of their crucial first six months on the market, evaluating those launches for their first six months. We’ve also added China to our cohort of critical Launch Excellence countries for the first time, recognising China’s dramatic rise in innovative launch potential, and bringing our core Launch Excellence countries to eight — the US, UK, Germany, France, Italy, Spain, Japan and China.
Starting with a short review of how the launch environment evolved to where it was pre-Pandemic, we turn immediately to the types of innovative launch we believe will thrive in the post-Pandemic environment, and the areas of focus — the Three Pillars of post-Pandemic Launch Excellence — which will drive success for those launches. We’ll then apply our Launch Excellence criteria to the pre-Pandemic launch cohort and analyse how the Pandemic cohort have fared. For detailed methodologies, turn to the Methodology.
In Launch Excellence VII, 6% of specialty launches are excellent internationally. 4% of primary care launches are excellent internationally.
As health systems recover and reach a new equilibrium, the legacy of the Pandemic will continue to affect which launches succeed, because the Pandemic has made substantial and very long-lasting changes to aspects of healthcare environment critical to launch.
Launch which have been proven to be resilient in the Pandemic environment, and have the clear potential to be in the post-Pandemic environment, fall into these categories.
This is the seventh Launch Excellence white paper that IQVIA has published since 2007, but never has the Launch Excellence environment changed so dramatically and comprehensively as in the last year. To respond, we've divided our launch cohort into a pre-pandemic cohort, which we have followed for 18 months of performance unaffected by the Pandemic, and the launches from late 2019, which have launched into the Pandemic during part or all of their crucial first six months on the market, evaluating those launches for their first six months.
The challenge of change: building Excellent launches in the post-pandemic environment
The missing piece for completing the patient-centricity puzzle
Optimal launch management through actionable foresight
